nature neuroscience advance online publication P e r s P e c t i V e Few topics in neuroscience are as controversial as the idea that calcium concentration elevations in astrocytes release transmitters that regulate neuronal and vascular function. As an example, highly respected scientists in the field have stated on the one hand 1 that astrocytes show "Ca 2+ -dependent quantal glutamate release … previously considered to be specific to synapses" and on the other hand 2 that "the case for regulated release of glutamate from astrocytes onto neurons … is not convincing" and 3 "it is very difficult to conclude that astrocytes possess the … machinery required for Ca 2+ -dependent release of glutamatergic vesicles." How could these mutually incompatible views arise? Here we review briefly the turbulent history of the field, survey recent data suggesting a way out of some of the reported contradictions, and speculate on the future direction of research in this area.
Few topics in neuroscience are as controversial as the idea that calcium concentration elevations in astrocytes release transmitters that regulate neuronal and vascular function. As an example, highly respected scientists in the field have stated on the one hand 1 that astrocytes show "Ca 2+ -dependent quantal glutamate release … previously considered to be specific to synapses" and on the other hand 2 that "the case for regulated release of glutamate from astrocytes onto neurons … is not convincing" and 3 "it is very difficult to conclude that astrocytes possess the … machinery required for Ca 2+ -dependent release of glutamatergic vesicles." How could these mutually incompatible views arise? Here we review briefly the turbulent history of the field, survey recent data suggesting a way out of some of the reported contradictions, and speculate on the future direction of research in this area.
The first wave: astrocytes also process information The discovery that glutamate evokes a calcium concentration rise in astrocytes [4] [5] [6] [7] [8] (in culture, in brain slices, in whole retina and in vivo), which can propagate along astrocyte processes and even between glial cells 4, 5, 7, 9, 10 , raised the possibility that glial Ca 2+ waves might constitute an extraneuronal signaling system in the CNS 7 . The subsequent demonstration that rises in intracellular Ca 2+ concentration ([Ca 2+ ] i ) in astrocytes in turn induce a [Ca 2+ ] i rise in adjacent neurons 11, 12 sparked a flurry of studies that generated the concept of gliotransmission from astrocytes to neurons.
Increases of astrocyte [Ca 2+ ] i evoked by receptor agonists such as glutamate and GABA, or by uncaging of Ca 2+ or inositol-1,4,5-trisphosphate (IP 3 ), were reported to release gliotransmitters from astrocytes, including glutamate 11, [13] [14] [15] [16] [17] [18] , ATP [19] [20] [21] , D-serine [22] [23] [24] and GABA [25] [26] [27] [28] . (It is unknown whether [Ca 2+ ] i also regulates the release of slower acting astrocyte-derived factors that regulate receptor expression at synapses, such as tumor necrosis factor-α, transforming growth factor-β1 and glypicans [29] [30] [31] .) The release of these gliotransmitters has been reported to generate a wide range of effects on neurons (summarized in Fig. 1 and described at length in ref. 32) . Glutamate release evokes an inward membrane current in neurons, mediated by NMDA receptors, that regulates excitability and synchronizes action potential firing [15] [16] [17] 33, 34 . Release of glutamate and GABA, and of ATP (which is converted to adenosine by extracellular ecto-ATPases), regulates synaptic vesicle release probability by activating presynaptic receptors 18, [35] [36] [37] [38] . The resulting effects on synaptic strength regulate whether synaptic plasticity can occur [39] [40] [41] , as does the release of D-serine, which controls the amount of NMDA receptor activation occurring when glutamate is released at synapses 22, 24 . These changes of neuronal function will modify information processing in circuit-specific ways, but a major high-level function of gliotransmitter release was suggested to be modulation of sleep induction, produced by the accumulation of adenosine derived from astrocyte-released ATP 42 .
In addition to altering neuronal information processing, calciumevoked release of messengers from astrocytes was suggested to regulate the energy supply to the brain in three important ways. First, increases of astrocyte [Ca 2+ ] i lead to the release of arachidonic acidderived messengers (such as prostaglandins, epoxyeicosatrienoic acids (EETs) and 20-hydroxyeicosatetraenoic acid (20-HETE)) that modify the contraction of vascular smooth muscle [43] [44] [45] . This provides a mechanism by which the polarized morphology of astrocytes-with many processes around synapses, and endfeet apposed to blood vessels-could regulate cerebral blood flow and energy supply 46 according to the activity of synapses, the main consumers of energy in the brain 47 . Second, glutamate-evoked rises in astrocyte [Ca 2+ ] i trigger the insertion of more glucose transporters into the cell membrane, facilitating glucose uptake from the blood when synapses are active 48 . Third, regulation of oxygen supply to the whole body may involve the acidification of brainstem astrocytes by CO 2 , which leads to a [Ca 2+ ] i rise and ATP release that in turn increases breathing rate 49 .
All this work led to the idea that astrocytes constitute a network of cells that process information and regulate brain energy supply in parallel with neurons. It culminated in the proposal that an increase in astrocyte size and complexity was crucial for the increase in central neural processing power that has occurred during hominid evolution 50 . This idea was reinforced by an increase in synaptic plasticity and learning seen in mice seeded with human astrocytes 51 , which propagate calcium waves four times as fast as rodent astrocytes 50 . Astrocytes therefore seemed to have come of age as players in information processing, and it was anticipated that disruptions of astrocyte calcium signaling might be important in diseases including epilepsy 52 , inflammation 53 , Alzheimer's disease 54 , Huntington's disease 55 and HIV infection 56 .
The second wave: the controversies Throughout these exciting developments, an increasing number of conceptual problems were arising with the mechanisms by which [Ca 2+ ] i is raised in astrocytes, the time course of that elevation, and the mechanisms by which gliotransmitters are released (Fig. 2) . These problems and, as we shall see later, their resolution arose in part from the methods used to study these phenomena. Demonstrating a role for gliotransmission in brain function requires the use of methods that manipulate astrocytes specifically. This has involved the use of drugs thought to alter [Ca 2+ ] i specifically in astrocytes (which is hindered by the fact that many receptors, while being expressed preferentially in astrocytes, are also expressed in neurons), the introduction into astrocytes of agents that manipulate signaling pathways (such as caged calcium or IP 3 , and tetanus or botulinum toxin), genetic manipulations that are astrocyte-specific, or the use of agents that disrupt astrocyte metabolism. It turns out that none of these provide a magic bullet to test the functional role of astrocyte [Ca 2+ ] i transients 32 .
G q -coupled metabotropic glutamate receptors (mGluRs, particularly mGluR5), which generate IP 3 that in turn releases calcium from internal stores, were suggested to initiate astrocyte calcium signaling 6, 13, 15, 43 59 include the fact that older, more ramified astrocytes may be less easily isolated with all their mRNA (some of which may be in their processes), that mRNA level may not predict protein level, that Ca 2+ signals appear to have been studied in the cells' somata rather than their processes, and hence that some mGluR5 may be present in the processes of adult astrocytes 61 .
The intracellular signaling pathway often supposed to translate increases of extracellular neurotransmitter concentration into astrocyte [Ca 2+ ] i transients-that is, the release of calcium from intracellular stores downstream of mGluR5 (or other G q -coupled receptors)-has similarly been criticized. Astrocyte processes very close to synapses have been reported to lack intracellular calcium stores 62 (although this may depend on fixation conditions 63 ) and so may be unable to respond to synaptic transmitter release with a [Ca 2+ ] i transient produced by store release. Furthermore, when the type 2 receptor for IP 3 (which is expressed far more in glia than in neurons 64 ) was knocked out, although this greatly reduced the number of [Ca 2+ ] i transients occurring in astrocyte somata 65, 66 , it had no effect on neuronal excitability 66 , synaptic currents 66 , synaptic plasticity 67 (although acetylcholineevoked long term potentiation was abolished 68, 69 ), neurovascular coupling 70, 71 or various behavioral assays 72 . Although it is hard to rule out developmental compensation in response to this lifelong deletion, these data challenged the notion that astrocyte [Ca 2+ ] i transients driven by IP 3 -evoked Ca 2+ release from internal stores release gliotransmitters that have a major influence on neuronal function.
Raising astrocyte [Ca 2+ ] i , by expressing in astrocytes a nonmammalian G q -coupled receptor that could be activated by an exogenous molecule (a designer receptor exclusively activated by a designer drug, or DREADD) 65, 70 , had no effect on neuronal [Ca 2+ ] i or excitability and did not modulate excitatory synaptic currents or evoke vascular effects. This is hard to reconcile with experiments showing that dialysis of astrocytes (from a patch pipette) with the calcium buffer BAPTA suppresses effects attributed to gliotransmitters 18, 35, 37 . To further complicate matters, raising [Ca 2+ ] i with a G q -coupled receptor can fail to evoke gliotransmitter release even when uncaging of calcium within astrocytes does 73 , and different G q -coupled receptors can have a very different efficacy for evoking gliotransmitter release 74 , suggesting that the subcellular localization of receptors with respect to internal calcium stores may be a crucial determinant of gliotransmitter release.
The mechanism by which [Ca 2+ ] i is raised in astrocytes will have an important influence on the speed of the [Ca 2+ ] i rise, which has ] i transients, prolonged controversy has existed over whether the release of gliotransmitters is mediated exocytotically 1, 37 (as reported in freshly dissociated and cultured astrocytes 78, 79 ) or by ion channels 27, 73, 80 (reviewed in detail in ref. 32 ). We will return to channel-mediated release below. Exocytosis, in the case of glutamate and GABA, requires the presence of vesicular glutamate and GABA transporters in astrocytes. Although these were detected for glutamate using immunocytochemistry and single-cell PCR 1 , their presence has been disputed on the basis of a lack of overlap of vesicular glutamate transporter (VGLUT) labeling with astrocyte markers (for the plasma membrane glutamate transporter GLT-1, the Ca 2+ -binding protein S100β and the water channel aquaporin 4) 81 , and transcriptome data do not detect Vglut1, Vglut2, Vglut3 or Vgat (the vesicular GABA transporter) in astrocytes 64 . RNA-sequencing data can yield false negatives, but these transporters are in fact detected in neurons, suggesting that VGLUT expression is genuinely low in astrocytes, although it is hard to rule out a highly spatially localized expression in astrocyte compartments that do not express GLT-1, S100β or aquaporin 4.
Exocytosis also requires the formation of a SNARE (soluble NSF attachment protein receptor) complex, which mediates Ca 2+ -dependent release of transmitter-filled vesicles. Although transcriptome data 64 suggest that some SNARE complex proteins are relatively selectively expressed in astrocytes (SNAP-23, VAMP3) or in neurons (SNAP-25, SNAP-47, VAMP2, syntaxin), there is no exclusively astrocytic component that could be knocked out to prevent transmitter exocytosis from astrocytes. Similarly, the potential calcium sensor for vesicle release that has the highest expression 64 in astrocytes, synaptotagmin XI, is also highly expressed in neurons. An innovative approach to suppressing astrocyte vesicle release was provided by expressing part of the SNARE molecule VAMP2 in astrocytes, driven (in a doxycycline-suppressible manner) by the Gfap (glial fibrillary acidic protein) promoter, to inhibit exocytotic release of transmitters from astrocytes 39 . This was found to alter synaptic transmission and plasticity 39 and to reduce the pressure to sleep 42 by suppressing the release from astrocytes of ATP, which is converted to adenosine by ecto-ATPases. The interpretation of this experiment depends crucially on expression of the transgene being specific to astrocytes, since VAMP2 is also involved in neuronal exocytosis. A paper re-examining this issue 82 suggested that the transgene was also expressed at a lower level (in a doxycycline-suppressible manner) in some neurons (defined by expression of the polysialylated neuronal cell adhesion molecule, PSA-NCAM), disagreeing with control experiments in the original reports 39, 42 and raising the question of whether the effects seen were dominated by alterations of exocytosis in astrocytes or in neurons 83 . The vigorous response published with ref. 82 (http://www.jneurosci. org/content/34/50/16594/reply#jneuro_el;112097) and recent data 84 supporting the notion of astrocyte-specific expression of the dominant negative SNARE show that this debate is not over yet, and the data suggesting neuronal expression 82 need to be confirmed by an independent laboratory (ideally using further neuronal markers). Nevertheless, the data in ref. 82 emphasize the importance of checking that supposedly astrocyte-specific transgenic lines are truly astrocyte-specific 85 . An alternative approach, injection of SNARE-cleaving toxins into astrocytes, has been shown to decrease gliotransmitter release 37, 86 , but it is hard to rule out the possibility that these agents (or the dominant negative SNARE) also affect trafficking to the surface membrane 87, 88 of ion channels that mediate release (see below) or alter other cellular processes such as autophagy 89 .
These controversies, over the receptors raising astrocyte [Ca 2+ ] i in response to neuronal activity, the involvement of internal calcium stores in producing [Ca 2+ ] i transients and the mechanism (if any) by which astrocytes release transmitters in response to rises in [Ca 2+ ] i , left the field in a prolonged state of uncertainty. Consequently, some have dismissed all the evidence as unsatisfactory 83 .
The third wave: partial resolution of the controversies The first hint of a possible explanation for some of these controversies came with the realization that, just like neurons, astrocytes must be considered as comprising many different subcellular compartments and that (easily detected) calcium transients occurring in the soma may not be telling the experimenter very much about what is happening in the fine astrocyte processes near synapses. Indeed, different astrocyte processes generate [Ca 2+ ] i transients at different times 90 , and 
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-/- Figure 2 The second wave controversies. 90, 93 , into the soma 93 and even between cells 92 . Both in dentate gyrus 96 and in hippocampal area CA1 (ref. 97) , introducing the Ca 2+ chelator BAPTA into an astrocyte leads to an increase in the rate of synaptic failures (but see ref. 99 , where a stronger stimulation strength was used; although the BAPTA concentration was high-75 mM-in one of these studies 96 , 10 mM BAPTA had the same effect 79, 97 96 , or glutamate and ATP or adenosine 97 , respectively), this work was a crucial step forward in the recognition that compartmentation of astrocyte [Ca 2+ ] i rises may explain some of the discrepancies in the literature.
The best example of the importance of astrocyte Ca 2+ compartmentation concerns the effect of knocking out IP 3 R2 receptors. Whereas the earlier reports 65-67,70-72 discussed above seemed to imply that most astrocyte [Ca 2+ ] i transients were abolished when IP 3 R2 was knocked out, it turns out that loss of this store-release receptor has much less effect in the fine processes of astrocytes than in the soma 93 100 . Interestingly, when IP 3 R2 receptors were knocked out, [Ca 2+ ] i rises evoked in astrocytes by endothelin were greatly reduced in the somata of the cells but much less affected in the processes, suggesting that Ca 2+ signaling evoked by this agonist may be mediated by release from internal stores in the soma but by direct coupling to a plasma membrane ion channel in the processes. Thus, there are major differences between Ca 2+ signaling in the somata and processes of astrocytes, and overall there are at least eight times as many Ca 2+ transients in processes than in somata 93, 100 . Consequently, previous conclusions [65] [66] [67] [70] [71] [72] 95 ). This raises the question of how [Ca 2+ ] i rises evoked in astrocyte processes around synapses lead to the release of vasoactive messengers at the spatially distant endfeet where astrocytes contact vessels. The lack of effect on blood flow responses of knocking out IP 3 R2 receptors rules out the possibility that a [Ca 2+ ] i wave produced by regenerative IP 3 generation and Ca 2+ release from endoplasmic reticulum stores propagates through the cell. Instead, either vasoactive messengers (NO or arachidonic acid derivatives) generated in astrocyte processes near synapses may diffuse to the nearest vessel, or a [Ca 2+ ] i wave generated by Ca 2+ -induced Ca 2+ release from stores mediated by ryanodine receptors 107 or by Ca 2+ -induced ATP release and activation of ATP receptors 108 may transmit the signal from the astrocyte's synapse-wrapping processes to its endfeet.
Other pathways that can raise [Ca 2+ ] i in astrocytes have also been suggested. For glutamate, the canonical G αi signaling pathway activated by mGluR2 and mGluR3 receptors inhibits cyclic AMP production; however, activation of these receptors (the expression of which, unlike that of mGluR5, has not been questioned in the adult 59 ) has been suggested to raise [Ca 2+ ] i in the processes of astrocytes 109 . This may involve activation of Ca 2+ release from stores or entry to the cell mediated by the G protein's βγ subunits. In addition, glutamate 75 and GABA 110 transporters have been suggested to raise astrocyte [Ca 2+ ] i in response to neuronal activity. This may be mediated by reversed operation of Na + /Ca 2+ exchangers 110 , following an uptake-evoked rise of [Na + ] i . Astrocyte [Ca 2+ ] i is also regulated by the modulatory neurotransmitters noradrenaline 111 (via α 1 receptors) and acetylcholine 112 (via muscarinic receptors), which are released from wide-ranging axons with somata in the locus coeruleus (a region involved in arousal, attention and memory) and the nucleus basalis of Meynert (an area involved in arousal, learning and reward), respectively. These npg Figure 3 The third wave and the future. 1. [Ca 2+ ] i transients in the processes of astrocytes (1a) differ from those in the soma (1b) in terms of frequency, kinetics and spatial spread. 2. [Ca 2+ ] i transients in the processes of astrocytes depend roughly equally on Ca 2+ entry (2a) from the extracellular space through ion channels (40%) and on Ca 2+ release from intracellular stores (60%), while those in the soma (2b) depend largely (90%) on Ca 2+ release from the intracellular stores. 3. [Ca 2+ ] i transients can be generated by Ca 2+ entry through spontaneously opening TRPA1 channels or neurotransmitter-gated channels (3a), by mGluR2 or mGluR3 (3b), and by neurotransmitter uptake raising [Na + ] i and reversing Na + /Ca 2+ exchange (3c). responses are developmentally regulated in the opposite direction to those generated by mGluR5, being barely detectable before the end of the first postnatal week 112 . Recent in vivo work has revealed that locomotion or an aroused state evoke a large noradrenalinemediated astrocyte [Ca 2+ ] i elevation over a broad spatial area 113, 114 , while stimulation of the nucleus basalis of Meynert evokes similar acetylcholine-mediated [Ca 2+ ] i elevations 69, 115 . Importantly, the noradrenaline results were obtained in unanesthetized animals and so were not compromised by the suppressive effect of anesthetics on astrocyte Ca 2+ transients 116 . The significance of these results is discussed below.
As indicated above, in our view the jury is still out on whether gliotransmitters are exocytosed from astrocytes, but new developments make that issue less crucial. First, recent work has provided molecular candidates for ion channels that have been suggested 80 to release neurotransmitters from astrocytes: both GABA and glutamate can be released from astrocytes via Ca 2+ -activated bestrophin-1 anion channels (despite the apparently low expression of mRNA for this channel in astrocytes 58, 64 ) and, surprisingly, normally K + -selective TREK (tandem of P-domains in a weakly inward rectifying K + channel-related K + channel) two-pore domain channels 27, 117, 118 . Furthermore, raising the proton concentration in cerebellar astrocytes (Bergmann glia) using channelrhodopsin evokes glutamate release via an as yet unidentified H + -gated mechanism (compare ref. 49 on brainstem astrocytes), and this mechanism contributes to glutamate release during ischemia 119 . Second, there is increasing awareness that changes in astrocyte [Ca 2+ ] i can have effects on neurons not by releasing substances but through changes in the activity of transporters in the astrocyte membrane. Astrocyte [Ca 2+ ] i rises mediated by TRPA1 channels increase the insertion of GABA transporters into the astrocyte membrane and thus regulate GABAergic effects on neurons without a need for the astrocyte to release GABA 95 . Similarly, G q -coupled mGluRs increase glutamate uptake currents 120 and membrane insertion of GLAST glutamate transporters 121 , and thus decrease glutamate effects on nearby neurons 121 124, 125 will also contribute to altering the efficiency of astrocyte transporters in regulating neurotransmitter effects on neurons. Finally, the increase of Na + /Ca 2+ exchange activity that is generated by increases of astrocyte [Ca 2+ ] i following transmitter-induced calcium release from internal stores has been reported to raise [Na + ] i sufficiently to increase sodium pump activity, leading to a decrease (or less increase during neuronal activity) of extracellular K + concentration ([K + ] o ) and local hyperpolarization of neurons 126 . This reduces spontaneous excitatory (but not inhibitory) synaptic activity, but decreases failures of action potential-evoked excitatory synaptic transmission 126 . The discovery of these mechanisms for modulating neuronal synaptic currents by altering astrocyte transmitter uptake or sodium pump activity implies that future studies wishing to attribute the effects of changes of astrocyte [Ca 2+ ] i to altered gliotransmitter release will first need to rule out (as in ref . 79) 2+ ] i rises, the field is on a more secure footing than it was 10 years ago (Fig. 3) . In this section we will highlight what we see as the most important questions to be resolved in the future. Methodological advances needed for this progress have been dealt with in three recent reviews [127] [128] [129] .
How 49 , cannabinoids 131, 132 , polyphosphate 133 and endothelin 134 in this regard. Although it has been widely assumed that most neuronally evoked astrocyte [Ca 2+ ] i transients reflect release of neurotransmitters at presynaptic terminals, neuronal depolarization may instead raise astrocyte [Ca 2+ ] i by action potential-evoked release of substances such as glutamate, ATP and cannabinoids from postsynaptic dendrites 132, 135 . Astrocyte Ca 2+ signaling and its effects are also, as for neuronal signaling, likely to show plasticity themselves 99 .
Which is more important: release of gliotransmitters or alteration of astrocyte membrane proteins? A gliotransmitter skeptic might assert that many of the phenomena attributed to gliotransmitter release can in fact be explained by astrocyte-intrinsic effects-specifically, changes in the activity or expression of membrane transporters. Thus, increases in the failure rate of action potential-evoked synaptic transmission seen when astrocyte [Ca 2+ ] i is buffered might theoretically reflect a reduction of the astrocyte Ca 2+ -evoked decrease of [K + ] o produced by increased sodium pump activity 126 , while changes in the amplitude of synaptic currents might reflect Ca 2+ -driven changes of neurotransmitter transporter level in the surface membrane of astrocytes 95, 120, 121 Does all this happen in other glia? While more than a decade of research has now been carried out on astrocyte Ca 2+ signaling, this area of research has barely begun for oligodendrocytes and microglia. The lessons learned from the pioneering studies of astrocyte [Ca 2+ ] i transients will surely be helpful to those studying whether Ca 2+ signaling is involved in regulating myelination or immune cell function.
Conclusion
From our perspective, the astrocyte Ca 2+ signaling field seems in robust good health. Controversies remain, but if one examines fields of neuronal physiology that are at a similar developmental stage-for example, the role of neuronal oscillations in brain function, determining what fMRI really measures, assessing how the cortical canonical circuit works, defining what the cerebellum does-they seem to show similar growing pains to those of the astrocyte Ca 2+ field. Constructively handled disagreements are a useful stimulus to further research. We look forward to the fourth wave.
